Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study. "Although the primary end point of the study (induction of remission) was not achieved, a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn's disease, compared with placebo, without side effects."
Reply to this Note | Notes Linking Here | Crohn's Cannabis | Prior Note
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study. "Although the primary end point of the study (induction of remission) was not achieved, a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn's disease, compared with placebo, without side effects."
...Read more
ICD 10 Diagnosis for Gastroenterology. Inpatient Gastroenterology. Hematemesis, hematochezia, melena, acute blood loss anemia, elevated liver enzymes, dysphagia esophagopharyngeal, epigastric abdominal pain, right upper quadrant abdominal pain, left upper quadrant abdominal pain, right lower quadrant abdominal pain, abnormal CT, ascites, hepatic encephalopathy, alcoholic cirrhosis, non-alcoholic cirrhosis, C. difficile diarrhea, acute pancreatitis, chronic pancreatitis, biliary pancreatitis, cannabis hyperemesis syndrome, cyclic vomiting syndrome, abnormal intraoperative cholangiogram.
...Read more